REGENCY
Freely Filtered discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.
Risk-Reducing Surgery Linked to Survival in Young BRCA Carriers
Successful HIV Viral Suppression With At-Home Administration
Modernization and the Rising Burden of IBD: New Insights From a Global Study